Advertisement

Smartphone medication adherence apps: Potential benefits to patients and providers: Response to Aungst

      We thank Dr. Aungst
      • Dayer L.
      • Heldenbrand S.
      • Anderson P.
      • et al.
      Smartphone medication adherence apps: potential benefits to patients and providers.
      for his comments and concerns regarding our recent publication.
      • Aungst T.D.
      Smartphone medication adherence apps: potential benefits to patients and providers: response to Dayer et al.
      Although our article was focused specifically on medication adherence applications (apps), we agree with his points regarding important considerations in selecting mobile medical apps in general. Like us, he recognizes the importance of pharmacists helping patients make informed app selections and decisions to improve medication adherence and overall maintenance of wellness. We agree that developer support and regular app updates are important considerations for patients when selecting an app.
      To read this article in full you will need to make a payment
      APhA Member Login
      APhA Members, full access to the journal is a member benefit. Use your society credentials to access all journal content and features
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Dayer L.
        • Heldenbrand S.
        • Anderson P.
        • et al.
        Smartphone medication adherence apps: potential benefits to patients and providers.
        J Am Pharm Assoc. 2013; 53: 172-181
        • Aungst T.D.
        Smartphone medication adherence apps: potential benefits to patients and providers: response to Dayer et al.
        J Am Pharm Assoc. 2013; 53: 344-345
      1. Department of Health & Human Services, Food and Drug Administration. Draft guidance for industry and Food and Drug Administration staff; mobile medical applications; availability. www.regulations.gov/#!documentDetail;D=FDA-2011-D-0530-0001. Accessed October 19, 2012.